Shares in Diversified Energy Company PLC (LSE:DEC, NYSE:DEC) rose 5% on Monday after the company posted what Peel Hunt called a solid first-quarter update, underpinned by stronger-than-expected revenues and steady cash generation.
The report is the first since DEC closed its acquisition of Maverick Natural Resources. Although only two weeks of Maverick’s production were included in the quarter, the numbers suggest meaningful progress.
Investors looking for exposure to stable, service-led growth in UK healthcare should take a closer look at Optima Health PLC (AIM:OPT), according to Panmure Liberum.
The occupational health and wellbeing provider reported full-year revenue of £105 million and adjusted EBITDA of £17.6 million, both meeting forecasts.
For investors seeking differentiated exposure to innovation in the drug development sector, Cavendish believes hVIVO PLC (AIM:HVO) offers a 'compelling' route in.
The company runs human challenge trials, a niche but increasingly strategic part of vaccine development that helps accelerate timelines and reduce costs for drugmakers.
Shares in N4 Pharma PLC (AIM:N4P) rose 10% on Monday after the company announced encouraging results from its first in vivo study using its Nuvec® delivery system for an oral treatment targeting Inflammatory Bowel Disease.
The AIM-listed biotech said both single and dual-loaded Nuvec particles, carrying siRNA and mRNA, reduced inflammation in mice with induced acute IBD.
For investors searching for undervalued names in the gold space, broker Cavendish believes Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) stands out as a compelling opportunity.
The Zimbabwe-based gold producer is trading well below its estimated fair value, despite strong free cash flow, consistent dividends and a positive outlook on production.
European Green Transition PLC (AIM:EGT) told investors it has secured a four-year extension for the Olserum #21 license in southeast Sweden.
The license, now extended to June 2029, covers close to 11 square kilometres near Gamleby and Vastervik.
Diversified Energy Company PLC (LSE:DEC, NYSE:DEC) showed strong results for the first quarter of 2025, supported by higher revenue and operational discipline.
The company reported total revenue of $295 million and earnings (adjusted EBITDA) of $138 million for the period.
Rome Resources Plc (AIM:RMR) has now confirmed the restart of drilling operations at the Bisie North site in the Democratic Republic of Congo.
Chief executive Paul Barrett told investors the company was “very pleased to be back to drilling”, and the team looks forward to completing the work in a timely manner.
Clinical trials group hVIVO PLC (AIM:HVO) will see two senior board members step down at its annual general meeting next month, including its long-serving chair Cathal Friel and non-executive director Martin Gouldstone.
Friel, who co-founded the business in 2017 and has chaired it for eight years, will leave the board after the 5 June meeting.
Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) delivered what chief executive Mark Learmonth described as an 'exceptional' first quarter, with higher production and surging gold prices lifting profits and cash flow.
The Zimbabwe-focused gold producer reported revenue of $56.2 million for the three months to 31 March, a 46% jump on the same period last year.
Optima Health PLC (AIM:OPT) CEO Jonathan Thomas hailed the 'outstanding progress' of the business as it said top-line growth would be in line with expectations, buoyed by organic growth and acquisitions.
The UK-based provider of corporate health and wellbeing services reported revenue of £105 million for the year to 31 March as it broadened its footprint through acquisitions and secured a major government contract.
Iofina PLC (AIM:IOF, OTC:IOFNF) has posted record annual revenue for the seventh year running, with strong early sales in 2025 pointing to continued demand for crystalline iodine.
The AIM-listed company, which processes oilfield brine to produce its end product, reported full-year revenue of $54.5 million for 2024, a 9% rise on the previous year.